PL
Polyrizon Ltd.
PLRZ · NASDAQ
$10.66 -3.35% (-$0.37)
1M -0.37%
Market Cap $11.9M
P/E Ratio -
Div. Yield -
ROE 16.94%
Bulios Fair Price
$6.95
34.8% downside
Current Price
$10.66
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PLRZ is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.57x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 29.77%
ROE 16.94%
ROA 15.56%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 29.03x
Int. coverage -1.99x
Stability
33 /100
Unstable Beta -1.34x
Profitable years 0
Rev. volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PLRZ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tomer Izraeli
Employees
6
Headquarters
Ra'anana